Citi raised the firm’s price target on Emerson (EMR) to $133 from $127 and keeps a Buy rating on the shares. Emerson earnings could be more resilient versus investor expectations given the company’s “strong” underlying profitability and “meaningful self-help opportunities,” the analyst tells investors in a research note. Citi views the stock’s recent de-rating as :having gone too far” versus the concerns that are out there given Emerson’s “favorable exposure” to secular long-term tailwinds and the company’s earnings quality. The stock remains a top pick at Citi.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Emerson Electric: Resilient Growth and Profitability Amid Strategic Initiatives and Market Potential
- Sell Recommendation for Emerson Electric Due to Overly Optimistic Growth Projections and Market Concerns
- Emerson price target lowered to $130 from $140 at Baird
- Emerson price target raised to $127 from $119 at Citi
- Emerson price target raised to $104 from $99 at Barclays
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue